2018
DOI: 10.1097/wco.0000000000000534
|View full text |Cite
|
Sign up to set email alerts
|

Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response

Abstract: Head-to-head comparison of treatment modalities such as VNS, DBS and RNS across different epileptic syndromes are required to decide which treatment modality is the most effective for a given patient scenario. Such studies are challenging and it is unlikely that data will be available in the near future. Additional data collection on potentially promising noninvasive neurostimulation modalities like tVNS, TMS, TNS and tDCS is warranted to get a more precise estimate of their therapeutic benefit and long-term s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
63
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(67 citation statements)
references
References 96 publications
0
63
0
1
Order By: Relevance
“…Vagus nerve stimulation (VNS) has been successfully used to reduce epileptic seizures in patients with drug-resistant epilepsy since 1988 (Krahl and Clark, 2012) and is clinically effective for many patients treated with invasive VNS (Boon et al, 2018;Kwon et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Vagus nerve stimulation (VNS) has been successfully used to reduce epileptic seizures in patients with drug-resistant epilepsy since 1988 (Krahl and Clark, 2012) and is clinically effective for many patients treated with invasive VNS (Boon et al, 2018;Kwon et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, neuromodulation therapy using various brain stimulation modalities, including deep brain stimulation, vagal nerve stimulation, or external responsive neurostimulation, have been attempted to control intractable seizures. 18 – 22 Those therapies modulate brain functions or pathological states at the entire brain network level, by stimulating the specific brain region to induce changes not only in the stimulated brain regions but also in distant areas that are connected to them through the anatomical or functional brain connectivity. While the neuromodulation therapies have been known as novel and promising treatment methods, demonstrating seizure reduction in about one-third to one-half of patients, 18 – 22 there are still many obstacles for improving the treatment efficacy by finding the optimal stimulation sites or stimulation parameters, or understanding the mechanisms behind the treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Instead, targeted approaches that only directly affect a small number of brain regions have been proposed. These techniques range from localised opening of the blood-brain-barrier through focused ultrasound [3,4], to invasive and non-invasive brain stimulation [5][6][7][8], and, when no alternative options are suitable, to surgical removal of brain tissue [9,10]. The problem then is to choose the right set of target regions for individual patients to maximize treatment effects and to minimize side effects.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, techniques used in the treatment of other diseases, like the coordinated reset [15,16] method (used for treatment of Parkinson's) that aims to desynchronise neuronal populations (pathological synchronization being a major feature of epilepsy) could potentially be used in treating epilepsy. The effectiveness of the methods used varies [7] and when it comes to TCS-one of the non-invasive methods-there are of contradictory results concerning its efficacy for treating epilepsy [17][18][19][20][21][22].…”
Section: Introductionmentioning
confidence: 99%